ivabradine has been researched along with Familial Primary Pulmonary Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biase, MD; Brunetti, ND; Correale, M; Montrone, D | 1 |
| Brunetti, ND; Correale, M; Di Biase, M; Ieva, R; Montrone, D | 2 |
3 other study(ies) available for ivabradine and Familial Primary Pulmonary Hypertension
| Article | Year |
|---|---|
Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Benzazepines; Cardiac Catheterization; Drug Therapy, Combination; Echocardiography, Doppler; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Heart Rate; Humans; Hypertension, Pulmonary; Ivabradine; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure; Scleroderma, Systemic; Time Factors; Treatment Outcome | 2012 |
Ivabradine in systemic sclerosis related pulmonary arterial hypertension.
Topics: Aged; Benzazepines; Familial Primary Pulmonary Hypertension; Female; Heart Failure; Humans; Hypertension, Pulmonary; Ivabradine; Middle Aged; Scleroderma, Systemic; Treatment Outcome | 2012 |
Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?
Topics: Aged; Antihypertensive Agents; Arterial Pressure; Benzazepines; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Ivabradine; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prostaglandins; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 2013 |